Schedule 13G ownership disclosure
ZYNERBA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98986X109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 672,316
- Percent of class
- 4.9600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-18-005337
- Form type
- SC 13G
- Filer
- BlackRock Finance, Inc.
- CIK
- CIK 1364742
- Filed
- Feb 09, 2018
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership